Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 188


Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.

Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, Junker A, Terkelsen CJ, Veien KT, Villadsen AB, Kaltoft A, Tilsted HH, Hansen KN, Aaroe J, Kristensen SD, Hansen HS, Jensen SE, Madsen M, Bøtker HE, Berencsi K, Lassen JF, Christiansen EH.

Circ Cardiovasc Interv. 2016 Jul;9(7). pii: e003610. doi: 10.1161/CIRCINTERVENTIONS.115.003610.


Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.

Jensen LO, Thayssen P, Christiansen EH, Maeng M, Ravkilde J, Hansen KN, Hansen HS, Krusell L, Kaltoft A, Tilsted HH, Berencsi K, Junker A, Lassen JF; SORT OUT IV Investigators.

J Am Coll Cardiol. 2016 Feb 23;67(7):751-62. doi: 10.1016/j.jacc.2015.11.051.


Intra- and interobserver reliability and intra-catheter reproducibility using frequency domain optical coherence tomography for the evaluation of morphometric stent parameters and qualitative assessment of stent strut coverage.

Antonsen L, Thayssen P, Junker A, Veien KT, Hansen HS, Hansen KN, Hougaard M, Jensen LO.

Cardiovasc Revasc Med. 2015 Dec;16(8):469-77. doi: 10.1016/j.carrev.2015.08.010. Epub 2015 Sep 10.


Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trial.

Jensen LO, Thayssen P, Maeng M, Ravkilde J, Hansen HS, Jensen SE, Bøtker HE, Berencsi K, Lassen JF, Christiansen EH.

Am Heart J. 2015 Aug;170(2):210-5. doi: 10.1016/j.ahj.2015.05.009. Epub 2015 May 22.


Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Nobori Stent Implantation in Patients With Non-ST-Segment-Elevation Myocardial Infarction (OCTACS) Trial: Difference in Strut Coverage and Dynamic Malapposition Patterns at 6 Months.

Antonsen L, Thayssen P, Maehara A, Hansen HS, Junker A, Veien KT, Hansen KN, Hougaard M, Mintz GS, Jensen LO.

Circ Cardiovasc Interv. 2015 Aug;8(8):e002446. doi: 10.1161/CIRCINTERVENTIONS.114.002446.


Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction.

Jensen LO, Terkelsen CJ, Horváth-Puhó E, Tilsted HH, Maeng M, Junker A, Lassen JF, Thuesen L, Sørensen HT, Thayssen P.

Am Heart J. 2015 Jul;170(1):70-8. doi: 10.1016/j.ahj.2015.03.020. Epub 2015 Apr 2.


Quantitative myocardial perfusion by O-15-water PET: individualized vs. standardized vascular territories.

Thomassen A, Petersen H, Johansen A, Braad PE, Diederichsen AC, Mickley H, Jensen LO, Gerke O, Simonsen JA, Thayssen P, Høilund-Carlsen PF.

Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):970-6. doi: 10.1093/ehjci/jev111. Epub 2015 May 5.


Very late stent thrombosis caused by neoatherosclerotic plaque rupture.

Hougaard M, Thayssen P, Hansen HS, Jensen LO.

EuroIntervention. 2015 Apr 22;10(12):e1-3. doi: 10.4244/EIJV10I12A251. No abstract available.


A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).

Maeng M, Baranauskas A, Christiansen EH, Kaltoft A, Holm NR, Krusell LR, Ravkilde J, Tilsted HH, Thayssen P, Jensen LO.

Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1161-7. doi: 10.1002/ccd.25875. Epub 2015 May 6.


Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.

Raungaard B, Jensen LO, Tilsted HH, Christiansen EH, Maeng M, Terkelsen CJ, Krusell LR, Kaltoft A, Kristensen SD, Bøtker HE, Thuesen L, Aarøe J, Jensen SE, Villadsen AB, Thayssen P, Veien KT, Hansen KN, Junker A, Madsen M, Ravkilde J, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT).

Lancet. 2015 Apr 18;385(9977):1527-35. doi: 10.1016/S0140-6736(14)61794-3. Epub 2015 Jan 16. Erratum in: Lancet. 2015 Apr 18;385(9977):1510.


Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

Olesen KK, Tilsted HH, Jensen LO, Kaltoft A, Krusell LR, Ravkilde J, Christiansen EH, Madsen M, Thayssen P, Sørensen HT, Lassen JF, Maeng M.

Am J Cardiol. 2015 Feb 1;115(3):298-302. doi: 10.1016/j.amjcard.2014.10.038. Epub 2014 Nov 11.


Large coronary intramural hematomas: a case series and focused literature review.

Antonsen L, Thayssen P, Jensen LO.

Cardiovasc Revasc Med. 2015 Mar;16(2):116-23. doi: 10.1016/j.carrev.2014.10.009. Epub 2014 Oct 31. Review.


Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.

Kristensen SL, Galløe AM, Thuesen L, Kelbæk H, Thayssen P, Havndrup O, Hansen PR, Bligaard N, Saunamäki K, Junker A, Aarøe J, Abildgaard U, Jeppesen JL.

PLoS One. 2014 Nov 19;9(11):e113399. doi: 10.1371/journal.pone.0113399. eCollection 2014.


Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.

Thim T, Johansen MB, Chisholm GE, Schmidt M, Kaltoft A, Sørensen HT, Thuesen L, Kristensen SD, Bøtker HE, Krusell LR, Lassen JF, Thayssen P, Jensen LO, Tilsted HH, Maeng M.

BMC Cardiovasc Disord. 2014 Aug 13;14:100. doi: 10.1186/1471-2261-14-100.


Intracoronary injection of CD34-cells in chronic ischemic heart failure: 7 years follow-up of the DanCell study.

Hansen M, Nyby S, Eifer Møller J, Videbæk L, Kassem M, Barington T, Thayssen P, Diederichsen AC.

Cardiology. 2014;129(2):69-74. doi: 10.1159/000363133. Epub 2014 Aug 12.


Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.

Jensen LO, Thayssen P, Maeng M, Christiansen EH, Ravkilde J, Hansen KN, Kaltoft A, Tilsted HH, Madsen M, Lassen JF; Scandinavian Organization for Randomized Trials With Clinical Outcome SORT OUT IV Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):840-8. doi: 10.1016/j.jcin.2014.02.014. Epub 2014 Jul 30.


Peri-stent contrast staining, major evaginations and severe malapposition after biolimus-eluting stent implantation: a case report based on coronary optical frequency domain imaging.

Antonsen L, Thayssen P, Jensen LO.

Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):424-7. doi: 10.1016/j.carrev.2014.04.006. Epub 2014 Apr 26.


Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.

Thayssen P, Lassen JF, Jensen SE, Hansen KN, Hansen HS, Christiansen EH, Junker A, Ravkilde J, Thuesen L, Veien KT, Jensen LO.

Circ Cardiovasc Interv. 2014 Apr;7(2):216-24. doi: 10.1161/CIRCINTERVENTIONS.113.000653. Epub 2014 Apr 8.


Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Maeng M, Tilsted HH, Jensen LO, Krusell LR, Kaltoft A, Kelbæk H, Villadsen AB, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Thuesen L, Madsen M, Thayssen P, Sørensen HT, Lassen JF.

Lancet. 2014 Jun 14;383(9934):2047-56. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14.

Items per page

Supplemental Content

Loading ...
Support Center